Article
Thermo Fisher's warning on more pain from biotech funding squeeze hits sector
Rating:
0.0
Views:
46
Likes:
1
Library:
1
Thermo Fisher Scientific on Wednesday signaled that a slump in demand from biotechs for its services used in making therapies and vaccines could extend into the next year, sending its shares tumbling more than 7% and weighing on the sector.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value